Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC)
暂无分享,去创建一个
[1] S. Pittaluga,et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy , 2022, Nature.
[2] Z. Al-Aly,et al. Long-term neurologic outcomes of COVID-19 , 2022, Nature Medicine.
[3] P. Lotufo,et al. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health , 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[4] V. Sehgal,et al. Myelitis Following COVID-19 Illness , 2022, Cureus.
[5] E. Wan,et al. Post-COVID-19 Condition. , 2022, Annual review of medicine.
[6] S. Efrati,et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial , 2022, Scientific Reports.
[7] T. Kent,et al. SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations , 2022, Ageing Research Reviews.
[8] J. Patcai. Is ‘Long Covid’ similar to ‘Long SARS’? , 2022, Oxford open immunology.
[9] O. Watson,et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study , 2022, The Lancet Infectious Diseases.
[10] J. Lieberman,et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation , 2022, Nature.
[11] T. Pollak,et al. Neuroimmune disorders in COVID-19 , 2022, Journal of Neurology.
[12] R. Bordet,et al. Long-term cognitive impairments following COVID-19: a possible impact of hypoxia , 2022, Journal of Neurology.
[13] Thomas E. Nichols,et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank , 2022, Nature.
[14] V. Balasubramaniam,et al. Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy , 2022, Frontiers in Microbiology.
[15] J. Olmos,et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study , 2022, Current medical research and opinion.
[16] B. Jarrott,et al. “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy , 2022, Pharmacology research & perspectives.
[17] Maria Papadopoulou,et al. Neurological manifestations of long-COVID syndrome: a narrative review , 2022, Therapeutic advances in chronic disease.
[18] Nelson B Rodrigues,et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis , 2021, Brain, Behavior, and Immunity.
[19] F. Kobeissy,et al. SARS-CoV-2 involvement in central nervous system tissue damage , 2021, Neural regeneration research.
[20] Xiao Li,et al. SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment , 2022, Frontiers in Microbiology.
[21] T. Robbins,et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. , 2021, Clinical medicine.
[22] H. Zhou,et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb , 2021, Cell.
[23] Hai Wang,et al. Predictors of Mortality in Hospitalized COVID-19 Patients Complicated With Hypotension and Hypoxemia: A Retrospective Cohort Study , 2021, Frontiers in Medicine.
[24] M. Kivipelto,et al. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions , 2021, Journal of Neurology.
[25] M. Kubo,et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism , 2021, Signal Transduction and Targeted Therapy.
[26] Edith Fabiola Mendez Elizondo,et al. Central Nervous System Injury in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: MRI Findings , 2021, Cureus.
[27] Urvish K. Patel,et al. Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis , 2021, Journal of medical virology.
[28] N. Rezaei,et al. Autoimmune complications of COVID‐19 , 2021, Journal of medical virology.
[29] Molly A Brady,et al. SARS-CoV-2: is there neuroinvasion? , 2021, Fluids and barriers of the CNS.
[30] H. Schiöth,et al. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms , 2021, Journal of Neuroimmunology.
[31] S. Basu,et al. Seizure after recovery from Covid-19 , 2021, Journal of family medicine and primary care.
[32] L. McCullough,et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection , 2021, Current Neurology and Neuroscience Reports.
[33] S. Jonjić,et al. Cytomegalovirus Infection and Inflammation in Developing Brain , 2021, Viruses.
[34] S. Yong. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments , 2021, Infectious diseases.
[35] Z. Shabani. Demyelination as a result of an immune response in patients with COVID-19 , 2021, Acta Neurologica Belgica.
[36] T. L. Wong,et al. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology , 2021, Medicina.
[37] R. Jayadevan,et al. Long COVID: An overview , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[38] A. Simpkins,et al. Post-COVID seizure: A new feature of “long-COVID” , 2021, eNeurologicalSci.
[39] S. Birring,et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses , 2021, The Lancet Respiratory Medicine.
[40] Abdullah Al Nahid,et al. Silent hypoxia in COVID-19: pathomechanism and possible management strategy , 2021, Molecular Biology Reports.
[41] V. Abedi,et al. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology , 2021, Frontiers in Cardiovascular Medicine.
[42] Ryan D. Chow,et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms , 2021, Cell Reports Medicine.
[43] J. Min,et al. SARS-CoV-2 cell tropism and multiorgan infection , 2021, Cell discovery.
[44] C. Taylor,et al. Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” , 2021, Annals of clinical and translational neurology.
[45] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[46] K. Melmed,et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications , 2021, Journal of the Neurological Sciences.
[47] Zhang Yan,et al. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2. , 2021, Journal of medical virology.
[48] David A. Drew,et al. Attributes and predictors of long COVID , 2021, Nature Medicine.
[49] Milad Asgari Mehrabadi,et al. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic , 2021, medRxiv.
[50] W. Banks,et al. Interactions of SARS-CoV-2 with the Blood–Brain Barrier , 2021, International journal of molecular sciences.
[51] A. Duits,et al. Neurologic sequelae of severe chikungunya infection in the first 6 months of life: a prospective cohort study 24-months post-infection , 2021, BMC Infectious Diseases.
[52] L. Østergaard. SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation , 2021, Physiological reports.
[53] E. Playford,et al. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline , 2021, BMJ.
[54] S. Villapol,et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis , 2021, Scientific Reports.
[55] R. Kream,et al. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce ‘Brain Fog’ and Results in Behavioral Changes that Favor Viral Survival , 2021, Medical science monitor : international medical journal of experimental and clinical research.
[56] S. Saffari,et al. Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors , 2020, Journal of Stroke and Cerebrovascular Diseases.
[57] I. Solomon,et al. What can we learn from brain autopsies in COVID-19? , 2020, Neuroscience Letters.
[58] Ryan J. Low,et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2020, EClinicalMedicine.
[59] Q. Lu,et al. COVID-19 and autoimmune diseases , 2020, Current opinion in rheumatology.
[60] C. Conrad,et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 , 2020, Nature Neuroscience.
[61] A. Aguzzi,et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID‐19 , 2020, Neuropathology and applied neurobiology.
[62] R. Sutton,et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. , 2020, Clinical medicine.
[63] E. Wood,et al. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.
[64] W. Heywood,et al. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. , 2020, F1000Research.
[65] P. Gaur,et al. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? , 2020, Stroke and vascular neurology.
[66] A. Khakshour,et al. VIRAL MENINGITIS ASSOCIATED WITH COVID-19 IN A 9-YEAR-OLD CHILD: A CASE REPORT. , 2020, The Pediatric infectious disease journal.
[67] A. Baig. Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers , 2020, Journal of medical virology.
[68] F. Nikbakht,et al. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms , 2020, Multiple Sclerosis and Related Disorders.
[69] I. Alquisiras-Burgos,et al. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection , 2020, Molecular Neurobiology.
[70] S. Naz,et al. Meningitis as an Initial Presentation of COVID-19: A Case Report , 2020, Frontiers in Public Health.
[71] E. Gulbins,et al. Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2 , 2020, The Journal of Biological Chemistry.
[72] G. Lippi,et al. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis , 2020, Acta bio-medica : Atenei Parmensis.
[73] M. Garcia-Gil,et al. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? , 2020, International journal of molecular sciences.
[74] Vasuki H. Dandu,et al. Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke , 2020, Cureus.
[75] T. Greenhalgh,et al. Management of post-acute covid-19 in primary care , 2020, BMJ.
[76] S. Salinas,et al. Neurocognitive impacts of arbovirus infections , 2020, Journal of Neuroinflammation.
[77] A. Paetau,et al. Neuropathologic features of four autopsied COVID‐19 patients , 2020, Brain pathology.
[78] K. Melmed,et al. Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19 , 2020, Stroke.
[79] H. Ejaz,et al. COVID-19 and comorbidities: Deleterious impact on infected patients , 2020, Journal of Infection and Public Health.
[80] C. de Waure,et al. Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir , 2020, Frontiers in Medicine.
[81] D. Pugin,et al. COVID‐19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients , 2020, Journal of Neuroimaging.
[82] S. Farhadian,et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.
[83] D. Ragab,et al. The COVID-19 Cytokine Storm; What We Know So Far , 2020, Frontiers in Immunology.
[84] Pardis C Sabeti,et al. Neuropathological Features of Covid-19 , 2020, The New England journal of medicine.
[85] J. Gómez-Arnau,et al. Covid-19 treatment-induced neuropsychiatric adverse effects , 2020, General Hospital Psychiatry.
[86] J. Bayry,et al. Autoimmune and inflammatory diseases following COVID-19 , 2020, Nature Reviews Rheumatology.
[87] S. Farhadian,et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. , 2020, JAMA neurology.
[88] N. Trotta,et al. Early postmortem brain MRI findings in COVID-19 non-survivors , 2020, Neurology.
[89] J. Marini,et al. Management of COVID-19 Respiratory Distress. , 2020, JAMA.
[90] S. Pavlakis,et al. Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child , 2020, Pediatric Neurology.
[91] R. M. Barrientos,et al. The impact of nutrition on COVID-19 susceptibility and long-term consequences , 2020, Brain, Behavior, and Immunity.
[92] R. Butowt,et al. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection , 2020, ACS chemical neuroscience.
[93] Haibo Xu,et al. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19 , 2020, Journal of Infection.
[94] T. Lv,et al. Encephalitis as a clinical manifestation of COVID-19 , 2020, Brain, Behavior, and Immunity.
[95] N. Enomoto,et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.
[96] Robert J. Mason,et al. Pathogenesis of COVID-19 from a cell biologic perspective , 2020, European Respiratory Journal.
[97] Hongming Miao,et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.
[98] E. Ely,et al. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms , 2019, Critical Care.
[99] S. Ferreira,et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice , 2019, Nature Communications.
[100] B. Lidbury,et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review , 2019, Diagnostics.
[101] Alexa B. R. McIntyre,et al. Altered m6A modification of specific cellular transcripts affects Flaviviridae infection , 2019, bioRxiv.
[102] G. Ippolito,et al. Tropism of the Chikungunya Virus , 2019, Viruses.
[103] L. Kedzierski,et al. Flavivirus Receptors: Diversity, Identity, and Cell Entry , 2018, Front. Immunol..
[104] Z. Chavoshzadeh,et al. Neurological Manifestations of Primary Immunodeficiencies , 2018, Iranian journal of child neurology.
[105] S. Irani,et al. Tocilizumab-associated multifocal cerebral thrombotic microangiopathy. , 2016, Neurology. Clinical practice.
[106] P. Garcez,et al. Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.
[107] R. Cohrs,et al. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. , 2015, The Journal of general virology.
[108] Anand Viswanathan,et al. Cerebral microbleeds: overview and implications in cognitive impairment , 2014, Alzheimer's Research & Therapy.
[109] A. Tselis. Epstein-Barr virus infections of the nervous system. , 2014, Handbook of clinical neurology.
[110] R. Rossaint,et al. Neurological outcome after experimental lung injury , 2011, Respiratory Physiology & Neurobiology.
[111] B. Stainsby,et al. Neuromusculoskeletal disorders following SARS: a case series. , 2011, The Journal of the Canadian Chiropractic Association.
[112] Mei-Ru Chen. Epstein–Barr Virus, the Immune System, and Associated Diseases , 2011, Front. Microbio..
[113] M. Albert,et al. Biology and pathogenesis of chikungunya virus , 2010, Nature Reviews Microbiology.
[114] G. Jahn,et al. Cytomegalovirus cell tropism. , 2008, Current topics in microbiology and immunology.
[115] P. Kennedy,et al. The neurotropic herpes viruses: herpes simplex and varicella-zoster , 2007, The Lancet Neurology.
[116] Jiang Gu,et al. Pathology and Pathogenesis of Severe Acute Respiratory Syndrome , 2007, The American Journal of Pathology.
[117] C. Prober,et al. Pathogenesis and disease , 2007 .
[118] D. Tirschwell,et al. Long-term neurological complications after hypoxic-ischemic encephalopathy. , 2006, Seminars in neurology.
[119] Zhang Zai-qian. Epstein-Barr Virus and Neurological Diseases , 2006 .
[120] B. Sellhaus,et al. S-100 Protein and Neurohistopathologic Changes in a Porcine Model of Acute Lung Injury , 2005, Anesthesiology.
[121] L. Schaade,et al. Neurological complications of acute and persistent Epstein‐Barr virus infection in paediatric patients , 2002, Journal of medical virology.
[122] C P Das,et al. Neurological complications of HIV infection. , 1998, Neurology India.
[123] H. Gendelman,et al. Human Immunodeficiency Virus Neurotropism: an Analysis of Viral Replication and Cytopathicity for Divergent Strains in Monocytes and Microglia , 1998, Journal of Virology.
[124] L. Weiner,et al. Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children. , 1996, The Pediatric infectious disease journal.
[125] N. Stocchetti,et al. Hypoxemia and arterial hypotension at the accident scene in head injury. , 1996, The Journal of trauma.
[126] J. McCutchan. Cytomegalovirus infections of the nervous system in patients with AIDS. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[127] R. Levy,et al. The neurologic complications of human immunodeficiency virus infection. , 1993, The Medical clinics of North America.
[128] A. M. Ramsay,et al. Myalgic encephalomyelitis--a persistent enteroviral infection? , 1990, Postgraduate medical journal.
[129] P. Behan,et al. The postviral fatigue syndrome--an analysis of the findings in 50 cases. , 1985, The Journal of infection.
[130] H. Stern. Cytomegalovirus Infection * , 1975, The British journal of clinical practice.
[131] B. Hemmer,et al. COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients Case Series , 2022 .